Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in Opioid Use Disorder
Phase 1
224
about 1.2 years
18–55
1 site in NJ
Why this study is shown
What this study is about
This trial is testing whether combining guanfacine with mindfulness meditation helps people who are already taking buprenorphine for opioid use disorder stay sober longer. This treatment involves taking a medication called guanfacine and participating in a mindfulness program.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Mindfulness Oriented Recovery Enhancement (MORE)
- 2.Take Guanfacine pharmacotherapy
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
CARDIOVASCULAR SYSTEM
oral (Oral Tablet)
Primary: Anxiety, Heart Rate, Mood
Psychiatry / Mental Health